Target Encoder

Medical coding automation for mapping CRF terms to MedDRA and WHODRUG dictionaries in clinical trials.

Overview

Target Encoder® is a secure, web-based medical coding tool developed by Target Health Inc., a full-service CRO and clinical trials software company. It is designed to code CRF (Case Report Form) terms to MedDRA and WHODRUG dictionaries, supporting coders, monitors, and administrators working on clinical trial data.

When CRF terms are entered into the system, each term is searched against the designated MedDRA or WHODRUG database. If multiple matches are found, the system presents a list of possible matches for the user to select from. If no match is found automatically, the coder can manually refine the term to identify an appropriate match. Manually entered terms are added to a user-defined dictionary, all manual coding actions can be reversed, and the system generates reports listing both automatically and manually coded terms.

Key Features and Capabilities

Access Control: Limits system access to authorized users, including coders, monitors, and administrators.
21 CFR Part 11 Compliance: Meets the federal mandate for electronic record systems.
MedDRA and WHODRUG Version Support: Compatible with multiple versions of each dictionary, with version numbers displayed on encoder screens.
MedDRA Dictionary: Incorporates the medical event terms and associated coding information dictionary published by MSSO.
WHO Drug Dictionary: Incorporates the medical product dictionary published by UMC.
User Defined Dictionary (UDD): Maintains a manually coded repository of CRF terms categorized by study.
Input Files: Accepts data from multiple input tables derived from multiple studies.
Output: Generates a database table of manually coded terms as well as a source database table.
Reports: Produces a Coded Table list and a Glossary.

Target Encoder® is delivered as a web-based platform and is fully integrated with the features required for medical coding workflows in clinical research settings. Its compliance with 21 CFR Part 11 makes it suitable for use in regulated pharmaceutical and clinical trial environments.